WuXi Biologics, a CDMO, launched the GMP operation of its new drug product facility DP5 located in Wuxi, China. The DP5 is the ninth operational drug product facility in the global network of WuXi ...
CHARLESTON, S.C., May 3, 2011 (GLOBE NEWSWIRE) -- Revolutions Medical Corporation ("Revolutions Medical" or the "Company") (OTCQB:RMCP) announces today that the Company has filed a provisional patent ...
WUXI, China, June 5, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global CRDMO service company, announced it has successfully launched the GMP operation of its new drug product ...
POMONA, Calif., Jan. 5, 2026 /PRNewswire/ -- Amsino International, Inc., a global manufacturer of single-use medical devices, announced the execution of an agreement with ampiezza. ampiezza, founded ...
POMONA, Calif., Feb. 3, 2026 /PRNewswire/ -- Amsino International, Inc. is pleased to announce a new three-year partnership with Partners Cooperative, effective January 1, 2026. This agreement ...
Please provide your email address to receive an email when new articles are posted on . The prefilled syringe is indicated for wet age-related macular degeneration, diabetic macular edema and retinal ...
LONDON--(BUSINESS WIRE)--Technavio has announced the top five leading vendors in their recent global pre-filled syringes market 2017-2021 report. This market research report also lists nine other ...
Novartis announces the launch in Europe of the Lucentis pre-filled syringe (PFS), which is specifically designed for intraocular injection The Lucentis PFS can lead to improved patient treatment via a ...
MIRAMAR, Fla., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (GNBT) (http://www.otcmarkets.com/stock/GNBT/quote), is pleased ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ipsen Biopharmaceuticals, an affiliate of Ipsen (Euronext: IPN; ADR: IPSEY), announced today that the United States Food and Drug Administration (FDA) has approved a ...
IRVINE, Calif. Teva Health Systems has introduced its adenosine injection, USP in a pre-filled syringe, the company announced Wednesday. Teva’s adenosine is AP rated to Astellas Pharma’s Adenocard IV ...